Cavernous malformation: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 9: Line 9:
   OMIM          = |
   OMIM          = |
   MedlinePlus    = |
   MedlinePlus    = |
  eMedicineSubj  = |
  eMedicineTopic = |
   MeshID        = |
   MeshID        = |
}}
}}

Revision as of 19:50, 3 December 2012

Cavernous malformation
MRI: Cavernous malformation.
(Image courtesy of RadsWiki)

WikiDoc Resources for Cavernous malformation

Articles

Most recent articles on Cavernous malformation

Most cited articles on Cavernous malformation

Review articles on Cavernous malformation

Articles on Cavernous malformation in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cavernous malformation

Images of Cavernous malformation

Photos of Cavernous malformation

Podcasts & MP3s on Cavernous malformation

Videos on Cavernous malformation

Evidence Based Medicine

Cochrane Collaboration on Cavernous malformation

Bandolier on Cavernous malformation

TRIP on Cavernous malformation

Clinical Trials

Ongoing Trials on Cavernous malformation at Clinical Trials.gov

Trial results on Cavernous malformation

Clinical Trials on Cavernous malformation at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cavernous malformation

NICE Guidance on Cavernous malformation

NHS PRODIGY Guidance

FDA on Cavernous malformation

CDC on Cavernous malformation

Books

Books on Cavernous malformation

News

Cavernous malformation in the news

Be alerted to news on Cavernous malformation

News trends on Cavernous malformation

Commentary

Blogs on Cavernous malformation

Definitions

Definitions of Cavernous malformation

Patient Resources / Community

Patient resources on Cavernous malformation

Discussion groups on Cavernous malformation

Patient Handouts on Cavernous malformation

Directions to Hospitals Treating Cavernous malformation

Risk calculators and risk factors for Cavernous malformation

Healthcare Provider Resources

Symptoms of Cavernous malformation

Causes & Risk Factors for Cavernous malformation

Diagnostic studies for Cavernous malformation

Treatment of Cavernous malformation

Continuing Medical Education (CME)

CME Programs on Cavernous malformation

International

Cavernous malformation en Espanol

Cavernous malformation en Francais

Business

Cavernous malformation in the Marketplace

Patents on Cavernous malformation

Experimental / Informatics

List of terms related to Cavernous malformation

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]


Cavernous malformations are cavernomas and cavernous angiomas. They are vascular malformations composed of closely approximated endothelial-lined sinusoidal collections without significant amounts of interspersed neural tissue (lack of intervening neural tissue is the only histopathologic characteristic that distinguishes these lesions from capillary telangiectasias).

Cavernous malformations are typically discrete multilobulated lesions that contain hemorrhage in various stages of evolution.

Nearly all cavernous malformations show evidence of recent and remote hemorrhage.

Cavernous malformations vary from several millimeters to several centimeters (usually <3 cm) in diameter.

Epidemiology

With the advent of MRI, cavernous malformation are currently the most commonly identified brain vascular malformations.

Multiple lesions are seen in approximately 15-33% of spontaneous cases.

A familial form of the disorder exists and is inherited as an autosomal dominant trait with variable expression. Multiple lesions are more common in the familial form, occurring in as many as 73% of patients.

Cavernous malformations also appear to be the most common CNS vascular malformation subtype in patients with mixed lesions. The most common combination include a developmental venous anomaly, which is identified in approximately 10-30% of patients with cavernous angiomas.

Risk Stratification

The clinical consequences of hemorrhage vary such that location becomes important.

Small hemorrhages in critical locations can have more severe effects, and thus, they are more likely to produce symptoms (eg, brainstem involvement).

Progressive neurologic deficits are more often associated with cavernous malformations in the infratentorial space and with lesions that demonstrate slow enlargement because of rebleeding episodes.

Diagnosis

Once patients become symptomatic, 40-50% present with seizures, 20% present with focal neurologic deficits, and 10-25% present with intracerebral parenchymal hemorrhage.

Symptoms may progress rapidly, be stable for years; or wax and wane, as in multiple sclerosis.

MRI

  • Popcorn-like, smoothly circumscribed, well-delineated complex lesions.
  • The core is formed by multiple foci of mixed signal intensities, which represents hemorrhage in various stages of evolution.
  • The heterogeneous core typically is surrounded completely by a low-signal-intensity hemosiderin rim on T1-weighted images. The hypointensity of this rim becomes more prominent, or blooms, on T2-weighted and gradient-refocused images because of the magnetic susceptibility effects.
  • Smaller cavernous malformations may appear as focal hypointense nodules with both T1- and T2-weighted sequences. The small lesions are depicted more clearly and are more numerous on gradient-echo images because of the increased susceptibility effects of the sequences.

Diagnostic Findings

(Images courtesy of RadsWiki)

Prognosis

The risk of hemorrhage is not well established, but it is estimated to be 0.2-2% per lesion per year.

This risk is increased in patients with established prior hemorrhage.

The lesions do not usually produce life-threatening hemorrhages because most hemorrhages associated with the lesions are small and of low pressure.

Cavernous malformations can occur at any age, but they are most likely to become clinically apparent in patients aged 20-40 years.

Frontal and temporal lobes are the most common sites of occurrence, and 80-90% of the lesions are supratentorial.

See Also

External Links


Template:WikiDoc Sources